SavedAdd your journal

Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 4

The effect of 17-alpha-hydroxyprogesterone caproate on 75 g oral glucose tolerance test results and the prevalence of gestational diabetes mellitus

Mefkure ERASLAN SAHİN
Ilknur Col MADENDAG
Pages
1126–1130
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, there was no statistically significant difference between the groups for GDM prevalence.Conclusion: The present study showed that 17-OHPC was importantly related to greater starvation, first hour, and second hourserum glucose levels compared with the healthy group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractAim: The goal of the present study was to investigate the effects of 17-alpha-hydroxyprogesterone caproate (17-OHPC) on oral glucose tolerance test (75 g OGTT) results and the prevalence of gestational diabetes mellitus (GDM).Material and Methods: : In the present case-control study, 1,472 pregnant women were enrolled.
📊
Key Findings & Data:Of these pregnant women, 146 had used 17-OHPC for at least one month between 16–24 weeks of gestation and the remaining 1,326 were the healthy control group.
💡
Conclusion & Impact:Additionally, there was no statistically significant difference between the groups for GDM prevalence.Conclusion: The present study showed that 17-OHPC was importantly related to greater starvation, first hour, and second hourserum glucose levels compared with the healthy group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AbstractAim: The goal of the present study was to investigate the effects of 17-alpha-hydroxyprogesterone caproate (17-OHPC) on oral glucose tolerance test (75 g OGTT) results and the prevalence of gestational diabetes mellitus (GDM).Material and Methods: : In the present case-control study, 1,472 pregnant women were enrolled. Of these pregnant women, 146 had used 17-OHPC for at least one month between 16–24 weeks of gestation and the remaining 1,326 were the healthy control group. Diagnostic criteria presented by International Association of Diabetes and Pregnancy Study Group were applied for diagnosis GDM.Results: Maternal demographic characteristics were similar between groups. The mean starvation serum glucose level was importantly greater in the study group at 81.7 ± 9.3mg/dL versus 79.6 ± 13.3mg/dL in the control group. Mean first hour serum glucose was 144.4 ± 30.4mg/dl in the study group and 130.8 ± 36.9mg/dl in the control group, importantly greater in the study group. Mean second hour serum glucose was importantly greater in the study group at 111.5 ± 26.1mg/dl versus 104.8 ± 31.4mg/dl in the control group. Additionally, there was no statistically significant difference between the groups for GDM prevalence.Conclusion: The present study showed that 17-OHPC was importantly related to greater starvation, first hour, and second hourserum glucose levels compared with the healthy group.

🔖

Cite This Article

SAHİN, M. E., MADENDAG, I. C. (2022). The effect of 17-alpha-hydroxyprogesterone caproate on 75 g oral glucose tolerance test results and the prevalence of gestational diabetes mellitus. Annals of Medical Research, Cilt: 27 - Sayı: 4, 1126–1130. https://ajindex.com/articles/446111

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Guo T, Wang Y, Zhang H, et al. The association between ambient temperature and the risk of preterm birth in China.Sci Total Environ 2018;613-14:439-46
  2. Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013;10:2
  3. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760-5
  4. Wu P, Gulati M, Kwok CS, et al. Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7
  5. Kim SA, Lee SM, Kim BJ, et al. The risk of neonatal respiratory morbidity according to the etiology of late preterm delivery. J Perinat Med 2017;45:129-34. 6. da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24
  6. O’Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30:687-96
  7. Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011;38:18-31
  8. Vivat V, Cohen-Tannoudji J, Revelli JP, et al. Progesterone transcriptionally regulates the beta 2-adrenergic receptor gene in pregnant rat myometrium. J Biol Chem 1992;267:7975-8
  9. Gaspar R, Ducza E, Mihalyi A, et al. Pregnancyinduced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone. Reproduction 2005;130:113-22
  10. Gyamfi C, Horton AL, Momirova V, et al. The effect of 17-alpha hydroxyprogesteronecaproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol 2009;201:392
  11. Madendag Y, Sahin E, Madendag Col I, et al. The effect of hyperemesis gravidarum on the 75 g oral glucose tolerance test screening and gestational diabetes mellitus. J Matern Fetal Neonatal Med 2018;31:1989-92
  12. Kim C, Liu T, Valdez R, et al. Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? A